Advertisement
Screener

RELMADA THERAPEUTICS, INC. (RLMD) Cash

2.8 / 5 stars · 68/120 Roast Me

RELMADA THERAPEUTICS, INC. Cash

RELMADA THERAPEUTICS, INC. (RLMD) had Cash of $42.52 million as of 2022-09-30, per its 10-Q filed 2022-11-10.

Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent

us-gaap:Cash · last filed 2022-11-10

  • 2022-09-30: Cash $42.52M.
  • 2022-06-30: Cash $37.26M.
  • 2022-03-31: Cash $44.93M.
  • 2021-12-31: Cash $44.44M.
Period endCash
2022-09-30$42.52M
10-Q · filed 2022-11-10
2022-06-30$37.26M
10-Q · filed 2022-08-11
2022-03-31$44.93M
10-Q · filed 2022-05-05
2021-12-31$44.44M
10-Q · filed 2022-11-10
2021-09-30$11.45M
10-Q · filed 2021-11-12
2021-06-30$4.67M
10-Q · filed 2021-08-10
2020-12-31$2.50M
10-Q · filed 2021-11-12
2014-02-28$2.63K
10-Q · filed 2014-04-15
2013-11-30$6.17K
10-Q · filed 2014-01-13
2013-08-31$15.29K
10-Q · filed 2014-04-15
2013-05-31$664.00
10-Q · filed 2013-07-12
2013-02-28$7.50K
10-Q · filed 2014-04-15
2012-11-30$10.45K
10-Q · filed 2014-01-13
2012-08-31$8.95K
10-Q · filed 2014-04-15
2012-05-31$12.29K
10-Q · filed 2013-07-12
2012-02-29$4.78K
10-Q · filed 2013-05-03
2011-08-31$3.01K
10-K · filed 2013-12-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
Rezolute, Inc. (RZLT)United States$0.382B-6.45
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63